Ryan Specialty Holdings, Inc. (RYAN)
—Data provided by IEX. Delayed 15 minutes.
Explore Other Stocks In...
Valuation Measures
Financial Highlights
Balance Sheet Strength
Similar Companies
Company Profile
Price Chart
Loading chart...
At a glance
• Delegated Authority Has Become the Engine: Ryan Specialty has fundamentally transformed its business model, with delegated authority revenue doubling to $1.4 billion and representing 47% of total revenue in 2025, up from 35% just two years prior. This shift toward managing general underwriter (MGU) operations creates higher-margin, more defensible revenue streams that are less susceptible to pure brokerage commission pressure.
• E&S Market Structural Tailwinds Meet Cyclical Property Headwinds: While the Excess & Surplus market has grown at a 10.6% CAGR since 2010 to capture 25.7% of U.S. commercial premium, Ryan Specialty faces near-term property pricing declines of 25-35% on large accounts. The company's diversification into casualty, professional lines, and reinsurance underwriting provides a buffer against these cyclical pressures.
• Investment Phase Masking Underlying Economics: The 31.7% Adjusted EBITDAC margin in 2025, down from 32.2%, reflects deliberate heavy investment in talent, technology, and the new Empower restructuring program. Management has deferred its 35% margin target beyond 2027, signaling a strategic choice to prioritize market share capture over near-term profitability.
• Capital Allocation Signals Management Conviction: The initiation of a $300 million share repurchase program in February 2026, combined with an 8% dividend increase, reflects management's view of a disconnect between valuation and long-term outlook. This comes despite maintaining a robust M&A pipeline, suggesting the company sees its own stock as an attractive investment opportunity.
• The Talent Moat Is Real But Expensive: With 96% producer retention and the establishment of Ryan Specialty University, the company has built a differentiated culture that attracts top-tier specialty insurance talent. However, this comes at a cost—compensation and benefits rose 13.3% in 2025, and new hires typically take 2-3 years to become fully accretive to earnings.
Growth Outlook
Profitability
Competitive Moat
How does Ryan Specialty Holdings, Inc. stack up against similar companies?
Financial Health
Valuation
Peer Valuation Comparison
Returns to Shareholders
Financial Charts
Financial Performance
Profitability Margins
Earnings Performance
Cash Flow Generation
Return Metrics
Balance Sheet Health
Shareholder Returns
Valuation Metrics
Financial data will be displayed here
Valuation Ratios
Profitability Ratios
Liquidity Ratios
Leverage Ratios
Cash Flow Ratios
Capital Allocation
Advanced Valuation
Efficiency Ratios
Ryan Specialty's Delegated Authority Transformation: Building a Capital-Light Underwriting Moat in a Softening Property Market (NYSE:RYAN)
Ryan Specialty Holdings is a specialty insurance intermediary focused on wholesale brokerage, binding authority, and underwriting management. It operates as a pure wholesale partner with no retail conflict, leveraging delegated underwriting authority to generate diversified, higher-margin revenue streams in the growing Excess & Surplus (E&S) market.
Executive Summary / Key Takeaways
-
Delegated Authority Has Become the Engine: Ryan Specialty has fundamentally transformed its business model, with delegated authority revenue doubling to $1.4 billion and representing 47% of total revenue in 2025, up from 35% just two years prior. This shift toward managing general underwriter (MGU) operations creates higher-margin, more defensible revenue streams that are less susceptible to pure brokerage commission pressure.
-
E&S Market Structural Tailwinds Meet Cyclical Property Headwinds: While the Excess & Surplus market has grown at a 10.6% CAGR since 2010 to capture 25.7% of U.S. commercial premium, Ryan Specialty faces near-term property pricing declines of 25-35% on large accounts. The company's diversification into casualty, professional lines, and reinsurance underwriting provides a buffer against these cyclical pressures.
-
Investment Phase Masking Underlying Economics: The 31.7% Adjusted EBITDAC margin in 2025, down from 32.2%, reflects deliberate heavy investment in talent, technology, and the new Empower restructuring program. Management has deferred its 35% margin target beyond 2027, signaling a strategic choice to prioritize market share capture over near-term profitability.
-
Capital Allocation Signals Management Conviction: The initiation of a $300 million share repurchase program in February 2026, combined with an 8% dividend increase, reflects management's view of a disconnect between valuation and long-term outlook. This comes despite maintaining a robust M&A pipeline, suggesting the company sees its own stock as an attractive investment opportunity.
-
The Talent Moat Is Real But Expensive: With 96% producer retention and the establishment of Ryan Specialty University, the company has built a differentiated culture that attracts top-tier specialty insurance talent. However, this comes at a cost—compensation and benefits rose 13.3% in 2025, and new hires typically take 2-3 years to become fully accretive to earnings.
Setting the Scene: The Specialty Insurance Intermediary Built for Complexity
Ryan Specialty Holdings, founded in 2010 by insurance legend Patrick G. Ryan, operates at the complex intersection of insurance distribution and delegated underwriting authority. Unlike traditional retail brokers, the company has maintained a strategic decision from inception to avoid retail operations entirely, thereby eliminating channel conflicts with its 35,000+ retail brokerage trading partners. This positioning allows Ryan Specialty to function as a pure-play wholesale partner rather than a competitor to its own client base—a structural advantage that fosters trust and drives the panel consolidation trend benefiting the company.
The company generates revenue through three distinct but complementary specialties. Wholesale Brokerage connects retail brokers to carriers for complex risks that admitted markets won't touch. Binding Authority provides delegated underwriting capacity for smaller, standardized commercial risks. Underwriting Management operates 39 MGUs that design, underwrite, and administer specialized programs on behalf of carriers. This three-pronged approach creates multiple revenue streams with different cyclicality and margin profiles.
Ryan Specialty sits at the center of a structural shift in insurance distribution. The E&S market has grown from 13.5% of total U.S. commercial insurance premium in 2010 to 25.7% in 2024, driven by the emergence of complex, high-hazard risks that admitted carriers cannot efficiently underwrite—severe convective storms, wildfires, social inflation, cyber threats, and novel health risks. The company's position as the second-largest U.S. P&C insurance wholesale broker and the largest P&C managing underwriter by premium volume gives it scale advantages in accessing both retail distribution and carrier capacity.
The competitive landscape reveals Ryan Specialty's unique positioning. Against giants like Aon (AON) and Willis Towers Watson (WTW), which offer broad consulting and advisory services, Ryan Specialty's pure intermediation focus enables faster execution and deeper specialization. Compared to Brown & Brown (BRO) and Arthur J. Gallagher (AJG), which operate hybrid retail-wholesale models, Ryan Specialty's channel conflict avoidance and "boutique-at-scale" culture attract top specialty talent. This talent advantage translates directly into better risk selection and superior organic growth—10.1% in 2025 versus 6% for AON, AJG, and WTW.
Technology, Products, and Strategic Differentiation: The "Boutique-at-Scale" Moat
Ryan Specialty's competitive advantage extends beyond relationships into technology and operational excellence. The 2025 rollout of a proprietary ChatGPT version for employees, generative AI for insurance submission intake, and an enhanced underwriter workbench represents more than incremental efficiency gains. These tools address a fundamental bottleneck in specialty insurance: the time and expertise required to analyze complex submissions. By automating routine tasks, the technology allows underwriters to focus on risk assessment, directly improving quote-to-bind ratios and retention rates.
The RT Connector digital marketplace exemplifies the company's platform strategy. Rather than merely facilitating transactions, Connector creates a network effect—more retail brokers attract more carriers, which in turn attracts more brokers. This transforms Ryan Specialty from a transactional intermediary into an essential infrastructure layer for specialty insurance distribution. The platform's value increases with each participant, creating switching costs that competitors struggle to replicate.
The Empower Program, launched in Q1 2026, represents a three-year, $160 million restructuring initiative designed to deliver $80 million in annual savings by 2029. This is a strategic optimization of brokerage, binding, and underwriting operations to accelerate data and technology strategies. The program targets scale efficiencies across all specialties while maintaining investment capacity. This signals that management recognizes the need to translate top-line growth into margin expansion through a deliberate, multi-year approach.
Talent development through Ryan Specialty University and the 96% producer retention rate create a durable human capital moat. In specialty insurance, relationships and expertise are paramount. The company's ability to attract and retain top-tier underwriters, actuaries, and brokers—evidenced by the 17 experts added through the USQ Risk acquisition—provides a competitive advantage that scales with the organization. Specialty insurance is fundamentally a knowledge business; the best talent wins the best risks, which generates the best results for carrier partners, attracting more capacity and better terms.
Financial Performance & Segment Dynamics: Growth Despite Headwinds
Ryan Specialty's 2025 financial results demonstrate resilience in a challenging environment. Total revenue of $3.05 billion grew 21% year-over-year, marking the seventh consecutive year of 20%+ top-line growth. This performance occurred despite the property pricing deterioration that accelerated throughout the year. The 10.1% organic growth rate still significantly outpaced the broader insurance brokerage industry and major public competitors.
The segment performance reveals a strategic transformation. Wholesale Brokerage grew 7.5% to $1.6 billion despite property pricing declines of 20-35% in the second half. When admitted carriers retrench from complex risks, retail brokers consolidate their wholesale relationships with the most capable partners. Ryan Specialty's scale and carrier access make it a primary choice, allowing it to capture market share even in a soft pricing environment.
Binding Authority, growing 15.5% to $370 million, demonstrates the value of delegated underwriting for small, tough-to-place commercial risks. This specialty benefits from E&S market tailwinds but operates with greater pricing stability due to its standardized nature. The acquisition of JM Wilson, adding $19 million in annual revenue and transportation expertise, supports the goal of becoming the national leader in Binding Authority.
Underwriting Management's 58.5% growth to $1.02 billion is a significant development. This segment now represents 34.2% of net commissions and fees, up from 21.3% in 2023. Delegated authority revenue across Binding Authority and Underwriting Management reached $1.4 billion, representing 47% of total revenue. This transformation from pure distributor to capital-light underwriter alters the company's economics. MGUs generate fee-based revenue that is less correlated with pricing cycles and more aligned with underwriting profitability.
The margin compression from 32.2% to 31.7% Adjusted EBITDAC reflects strategic investment. Compensation and benefits increased $212 million to support 815 new employees, while general and administrative expenses rose $101 million due to professional services and IT charges. Amortization jumped $116 million from acquisition-related intangibles, and interest expense increased $64 million from acquisition debt. These are growth investments rather than operational inefficiencies.
Cash flow generation remains robust, with operating cash flow of $644 million in 2025, up from $515 million in 2024. The company deployed $747 million in acquisitions while maintaining leverage at 3.2x net debt to credit EBITDA. The $300 million share repurchase authorization signals that management believes the stock is undervalued despite trading at 14.1x EV/EBITDA.
Outlook, Management Guidance, and Execution Risk
Management's 2026 guidance reflects a realistic assessment of cyclical pressures. Organic revenue growth is projected in the high single digits, a moderation from previous years. This guidance assumes continued property pricing declines similar to the 25-35% drops seen in late 2025, combined with moderating casualty growth. The assumption that admitted carriers will not meaningfully re-enter small commercial segments in 2026 is a key factor in this outlook.
The Adjusted EBITDAC margin guidance of flat to moderately down acknowledges several factors: lower interest rates reducing fiduciary investment income, stabilization of contingent commissions , increased healthcare costs, and continued investment in talent. The deferral of the 35% margin target beyond 2027 indicates management will not sacrifice long-term positioning for short-term margin optimization.
Q1 2026 is expected to be a strong quarter for organic growth, aided by Ryan Re, the reinsurance MGU that has expanded its breadth. The strategic partnership with Nationwide Mutual (NFS) to underwrite Markel's (MKL) reinsurance renewal rights book demonstrates the ability to win large, complex mandates. This diversification into reinsurance provides a growth vector uncorrelated with primary insurance cycles.
The Empower program's $80 million annual savings target by 2029 creates a path to margin expansion, though benefits will ramp gradually. With $160 million in cumulative one-time charges through 2028, the program represents a significant near-term investment. This suggests margins may remain pressured through 2027 before potentially accelerating in 2028-2029.
Execution risk centers on property pricing stabilization, casualty market moderation, and M&A integration. Management views current property softness as cyclical rather than structural. However, if pricing declines extend beyond 2026, the ability to offset through market share gains will be tested. The casualty moderation acknowledges that carriers are becoming more competitive, which could pressure the rate increases that drove 2025 performance.
Risks and Asymmetries: What Could Break the Thesis
Property market volatility represents an immediate risk. The 25-35% pricing declines on large accounts in late 2025 create a revenue headwind that market share gains may not fully offset. If this deterioration continues into 2027, maintaining high single-digit organic growth becomes more difficult, given that property is a meaningful portion of Wholesale Brokerage revenue.
The casualty market presents the risk of moderation. While management anticipates strong growth in 2026, carriers are becoming more constructive about growing in casualty, introducing competition. This could compress rate increases in high-hazard lines like transportation and healthcare. If both property and casualty segments soften simultaneously, diversification benefits may diminish.
Talent retention risk has intensified due to regulatory shifts. Potential changes to non-compete clause enforcement could impact the ability to prevent key producers from joining competitors. While the 96% producer retention rate is high, it may become harder to maintain if talent mobility increases. Specialty insurance relies heavily on relationships, and losing top underwriters could impact risk selection.
MGA incentive alignment remains a structural risk. The MGU model can create potential misalignment where growth incentives conflict with underwriting discipline. Ryan Specialty's governance platform and the ability to curtail specific lines mitigate this, but underwriting failures could damage carrier relationships. This risk intensifies as the platform grows to over $10 billion in managed premium.
M&A integration risk is present given the pace of acquisitions—12 deals for $2.7 billion over two years. The 73.9% increase in amortization expense in 2025 reflects the accounting impact of these deals. Cultural integration of entrepreneurial MGU founders into the larger platform while maintaining their innovative edge is a continuous management task.
Valuation Context: Growth at a Reasonable Price
At $33.04 per share, Ryan Specialty trades at an enterprise value of $12.1 billion, representing 3.97x trailing revenue and 14.06x trailing EBITDA. These multiples sit at a discount to several direct peers: Brown & Brown trades at 5.03x revenue and 14.64x EBITDA, and Arthur J. Gallagher at 4.75x revenue and 19.05x EBITDA. Aon trades at 4.83x revenue and 14.66x EBITDA. Only Willis Towers Watson trades at a lower revenue multiple (3.21x).
The valuation discount relative to peers is notable given the company's organic growth profile. The 10.1% organic growth in 2025 compares favorably to the 6% seen at AJG, AON, and WTW. This suggests the market may be pricing in margin pressure or execution risk around the M&A strategy. The initiation of a $300 million share repurchase program indicates management believes this discount is unwarranted.
Cash flow metrics show the company trades at 15.16x price-to-free-cash-flow and 13.56x price-to-operating-cash-flow. The 1.57% dividend yield signals a commitment to returning capital. The 2.82x debt-to-equity ratio is higher than some peers but remains within the targeted 3-4x leverage corridor for credit purposes.
The 70.30 P/E ratio reflects the margin investment cycle and acquisition-related amortization. With $116.6 million in incremental amortization in 2025, GAAP earnings do not fully reflect cash generation. The 18.21% return on equity reflects growth investments and acquisition accounting. As the Empower program delivers savings, ROE has the potential to improve.
Conclusion: A Transformed Platform Navigating Cyclicality
Ryan Specialty has transitioned from a wholesale broker to a capital-light underwriting platform, with delegated authority now representing nearly half of revenue. This shift creates a business model that leverages underwriting expertise and carrier relationships. The structural expansion of the E&S market provides a tailwind that should persist as complexity drives business out of admitted markets.
The near-term outlook is affected by property pricing declines and moderating casualty growth, but guidance of high single-digit organic growth reflects confidence in market share gains and reinsurance expansion. The Empower program's $80 million annual savings target by 2029 creates a path to margin expansion, while the share repurchase signals conviction in the valuation.
The investment thesis depends on the duration of property market softness and the integration of recent acquisitions. If property pricing stabilizes in 2027 and the company maintains underwriting discipline while scaling, Ryan Specialty is positioned to emerge from this cycle with a stronger competitive standing. The company offers exposure to the structural growth of specialty insurance distribution with a management team that balances aggressive investment with shareholder returns.
If you're interested in this stock, you can get curated updates by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.
Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.
Loading latest news...
No recent news catalysts found for RYAN.
Market activity may be driven by other factors.
Want updates like this for other stocks you follow?
You only receive important, fundamentals-focused updates for stocks you subscribe to.
Subscribe to updates for: